Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Change in Account Payables (2016 - 2017)

Historic Change in Account Payables for Rocket Pharmaceuticals (RCKT) over the last 2 years, with Q4 2017 value amounting to $68000.0.

  • Rocket Pharmaceuticals' Change in Account Payables rose 13675.68% to $68000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.1 million, marking a year-over-year decrease of 268292.68%. This contributed to the annual value of -$1.1 million for FY2017, which is 268292.68% down from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Change in Account Payables of $68000.0 as of Q4 2017, which was up 13675.68% from $15000.0 recorded in Q3 2017.
  • In the past 5 years, Rocket Pharmaceuticals' Change in Account Payables ranged from a high of $856000.0 in Q3 2016 and a low of -$1.5 million during Q2 2017